June 10, 2021
Rising elderly populace with surge in incidences of Hypertensive Vascular Disease (HVD), coupled with cognizance about the ailment & it’s treatment are the major factors leading to augmentation of global tissue heart valves / cardiovascular prosthetic devices industry. Additionally, governmental support for cardiac valve studies, along with regulatory approvals for advanced prosthetic heart valves are also propelling the market growth.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3557536/
It is to be noted that mechanical heart valve is implanted in those who are diagnosed with diseases like mitral regurgitation and aortic stenosis. Tissue heart valves eliminates the need for anticoagulation drugs for a long time and these devices have an average lifespan of 15 to 20 years.
On the contrary, expensive transcatheter heart valve devices, difficult procedures along with adverse reimbursing policies are likely to impede the growth of global tissue heart valves / cardiovascular prosthetic devices industry.
Based on type of valve, the market is divided into tissue heart valve, mechanical heart valve, and transcatheter heart valve. Speaking of type, worldwide tissue heart valves / cardiovascular prosthetic devices industry is classified into pulmonary valve, aortic valve, tricuspid valve, and mitral valve. In terms of end user terrain, the market is segregated into ambulatory surgical centers, and hospitals.This business intelligence documentation is prepared with the help of opinions of KOL and SME as well as the PEST analysis. Vital insights based on prevailing trends are provided in the report, with emphasis on unveiling the profitable opportunities.
Considering the geographical landscape, the report provides market scenario in nations like the United States, the United Kingdom, Japan, Germany, France, Italy, and Spain. Industry share held by each country, alongside their growth prospects and revenue garnered are presented.
The competitive landscape of worldwide tissue heart valves / cardiovascular prosthetic devices market is defined by companies such as Edwards Lifesciences, St. Jude Medical Inc., Medtronic plc, Colibri Heart Valve LLC, LivaNova plc, CryoLife Inc., Braile Biomédica, Boston Scientific Corporation, Symetis SA, TTK Healthcare Ltd. (TTKHC), JenaValve Technology Inc., and Lepu Medical Technology (Beijing) Co. Ltd. among others.